SEOUL, South Korea,
Nov. 28, 2021 /PRNewswire/ -- South
Korean artificial intelligence (AI) developer VUNO Inc. announced
that it will join the Radiological Society of North America 2021 (RSNA 2021), one of the
biggest annual events, featuring a series of industry symposia in
radiology. This year, VUNO will highlight real world clinical value
that its powerful AI technology has been able to successfully
demonstrate in radiologists' workflow as well as in the patient
journey. This exhibition will be held at McCormick Place Chicago,
Nov. 28-Dec.2, 2021. For further information, visit VUNO's RSNA2021
website (https://rsna2021.vuno.co/).
VUNO will showcase four medical artificial intelligence
solutions: VUNO Med®-Chest
X-Ray™, VUNO Med®–LungCT AI™, VUNO
Med®-DeepBrain® and VUNO
Med®-BoneAge™ that can
be seamlessly integrated with PACS(Picture Archiving and
Communication System), EMR(Electronic Medical Record) systems or
any medical devices. A virtual reading room linked to the PACS
system will be set up in the VUNO booth so that visitors can
get a first-hand look at VUNO Med® solutions that
integrated with PACS.
VUNO will present the future R&D direction of VUNO at the AI
Theater under the topic 'The Past, Present and the Future of VUNO
Med for Precision Imaging.' Following that, nine research
achievements will be presented at a research presentation session.
It includes topics encompassing various medical imaging fields,
such as MRI-based AI model in prediction of MCI to dementia,
AI-aided diagnosis to diagnose lung nodule malignancy, basal lung
metastasis in colon cancer patients.
Furthermore, VUNO will participate in IAIP (Imaging AI in
Practice), a virtual demonstration program developed to effectively
demonstrate the effects of AI solutions in clinical settings. The
company will showcase VUNO Med®–LungCT AI™ on this
program to demonstrate how it works by using real-world clinical
scenarios.
Hyun-Jun Kim, CEO of VUNO said,
"Through RSNA 2021 participation, we will introduce various
clinical research achievements to global radiology officials using
AI technology," Hyun-jun Kim, CEO of VUNO said, adding "we plan to
expand our partnerships with overseas partner companies and medical
institutions by offering an opportunity for participants to
directly experience VUNO Med® solutions."
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vuno-boasts-of-its-ai-solutions-and-research-results-at-rsna-2021-301432332.html
SOURCE VUNO Inc.